Status: current, Defined. Date: 31-Jan 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3607981000168117 | Brenda-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3607991000168119 | Brenda-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4099991000168117 | Brenda-35 ED (cyproterone acetate 2 mg + ethinyloestradiol 35 microgram) tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Brenda-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Brenda-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Brenda-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | Is a | Brenda-35 ED | true | Inferred relationship | Some | ||
| Brenda-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | Is a | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet | true | Inferred relationship | Some | ||
| Brenda-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | has manufactured dose form | sugar coated tablet | false | Inferred relationship | Some | ||
| Brenda-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | has unit of use | tablet | true | Inferred relationship | Some | 2023711251 | |
| Brenda-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | has intended active ingredient | cyproterone | true | Inferred relationship | Some | 851945333 | |
| Brenda-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | has Australian BoSS | cyproterone acetate | true | Inferred relationship | Some | 851945333 | |
| Brenda-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | has intended active ingredient | ethinylestradiol | true | Inferred relationship | Some | 2023711250 | |
| Brenda-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | has Australian BoSS | ethinylestradiol | true | Inferred relationship | Some | 2023711250 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Brenda-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 28, blister pack | has TPUU | True | Brenda-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | Inferred relationship | Some | 2 |
| Brenda-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 28 | has TPUU | True | Brenda-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | Inferred relationship | Some | 1 |
| Brenda-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28, blister packs | has TPUU | True | Brenda-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | Inferred relationship | Some | 2 |
| Brenda-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28 | has TPUU | True | Brenda-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | Inferred relationship | Some | 3 |
Reference Sets
Trade product unit of use reference set
FHIR